Healthcare · Pharmaceutical spending per capita
Iran's pharmaceutical market, one of the largest in the Middle East, demonstrates resilience thanks to an import substitution program. Per capita spending of 170 $ dollars (87th out of 197 in 2026) reflects the affordability of basic medicines, but high prices for innovative drugs, especially under inflation, remain a serious barrier for patients.
Data for 2026 · unit: $
Position
#87 / 197
Iran world ranking
Country position on the scale from last to first place for this indicator.
IR
#87
#197#1
Trend
Change over time
Change in indicator over the available period.
30
1990
60
2000
120
2010
155
2020
170
2026
Values — $
Comparison
Top countries by Pharmaceutical spending per capita
Where Iran stands in the world ranking.
1
MCMonaco
1.9 K
2
USUSA
1.4 K
3
LILiechtenstein
1.3 K
4
LULuxembourg
1.2 K
5
JPJapan
950
5
CACanada
950
7
CHSwitzerland
920
8
SMSan Marino
850
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical spending per capita in Iran — how much?
Based on 2026 data — 170 $. This is rank #87 out of 197 countries.
What is Iran's rank by Pharmaceutical spending per capita?
Iran ranks #87 out of 197 countries in the world ranking by «Pharmaceutical spending per capita».
How has Pharmaceutical spending per capita changed in Iran?
Over the available period the indicator changed from 30 to 170 $.